UCP2 and breast carcinoma: The treatment of MDA-MB-231 breast cancer cells with flavonoids (IC50 = 350 μM) resulted in a decrease in UCP2 gene expression, which was observed from 48 to 72 h of incubation with the flavonoid (Figure 2A).